Bhaskar Das

Title: Bhaskar Das: Innovator in Fibrosis and Cancer Treatment

Introduction

Bhaskar Das is a notable inventor based in West Nyack, NY (US). He has made significant contributions to the field of medical research, particularly in the development of treatments for fibrosis and cancer. His innovative work has led to the creation of a patent that showcases his expertise and dedication to improving health outcomes.

Latest Patents

Bhaskar Das holds a patent for "HCK inhibitors for the treatment of fibrosis and cancer." This patent includes compounds that are oxadiazaborole derivatives, which are identified as inhibitors of hematopoietic cell kinase (HCK). These compounds exhibit anti-fibrotic and anti-proliferative effects, making them useful in treating various disorders, including renal fibrosis.

Career Highlights

Throughout his career, Bhaskar Das has worked with prestigious institutions, including the Icahn School of Medicine at Mount Sinai and the United States Government as represented by the Department of Veterans Affairs. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of Bhaskar Das's notable coworkers include Barbara Murphy and Chengguo Wei. Their collaborative efforts have further advanced the research and development of innovative treatments in the medical field.

Conclusion

Bhaskar Das is a distinguished inventor whose work in developing HCK inhibitors has the potential to transform the treatment of fibrosis and cancer. His contributions to medical research reflect his commitment to improving patient care and advancing scientific knowledge.